Delcath Systems, Inc. (DCTH)
16.11
-0.14
(-0.86%)
USD |
NASDAQ |
Sep 18, 16:00
16.11
0.00 (0.00%)
After-Hours: 20:00
Delcath Systems Enterprise Value : 464.55M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 464.55M |
| September 17, 2026 | 469.40M |
| September 16, 2026 | 468.36M |
| September 15, 2026 | 466.63M |
| September 14, 2026 | 475.98M |
| September 11, 2026 | 457.62M |
| September 10, 2026 | 453.81M |
| September 09, 2026 | 460.05M |
| September 08, 2026 | 463.51M |
| September 04, 2026 | 477.37M |
| September 03, 2026 | 477.37M |
| September 02, 2026 | 480.83M |
| September 01, 2026 | 474.60M |
| August 31, 2026 | 476.67M |
| August 28, 2026 | 472.52M |
| August 27, 2026 | 474.25M |
| August 26, 2026 | 474.60M |
| August 25, 2026 | 492.61M |
| August 24, 2026 | 486.72M |
| August 21, 2026 | 500.23M |
| August 20, 2026 | 486.72M |
| August 19, 2026 | 500.57M |
| August 18, 2026 | 490.53M |
| August 17, 2026 | 497.11M |
| August 14, 2026 | 486.03M |
| Date | Value |
|---|---|
| August 13, 2026 | 507.85M |
| August 12, 2026 | 499.19M |
| August 11, 2026 | 503.00M |
| August 10, 2026 | 483.95M |
| August 07, 2026 | 429.92M |
| August 06, 2026 | 442.38M |
| August 05, 2026 | 344.02M |
| August 04, 2026 | 361.68M |
| August 03, 2026 | 358.22M |
| July 31, 2026 | 329.82M |
| July 30, 2026 | 323.58M |
| July 29, 2026 | 307.65M |
| July 28, 2026 | 306.61M |
| July 27, 2026 | 320.12M |
| July 24, 2026 | 329.82M |
| July 23, 2026 | 337.09M |
| July 22, 2026 | 340.55M |
| July 21, 2026 | 350.25M |
| July 20, 2026 | 342.63M |
| July 17, 2026 | 350.25M |
| July 16, 2026 | 351.64M |
| July 15, 2026 | 363.07M |
| July 14, 2026 | 361.68M |
| July 13, 2026 | 352.33M |
| July 10, 2026 | 357.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 205.21B |
| AngioDynamics, Inc. | 600.95M |
| Alphatec Holdings, Inc. | 2.063B |
| AtriCure, Inc. | 2.862B |
| Baxter International, Inc. | 18.47B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.668M |
| Revenue (Quarterly) | 29.13M |
| Total Expenses (Quarterly) | 26.46M |
| EPS Diluted (Quarterly) | 0.0671 |
| Gross Profit Margin (Quarterly) | 89.75% |
| Profit Margin (Quarterly) | 9.16% |
| Earnings Yield | 0.04% |
| Normalized Earnings Yield | 0.0379 |